It is common for sponsors to switch digital platforms between clinical trial phases, but sponsors can achieve much by using ...

Immutep has concluded subject enrolment in the Phase II segment of the AIPAC-003 trial of eftilagimod alpha (efti) to treat ...

The trial enrolled individuals with EGFRm, locally advanced or metastatic non-squamous non-small cell lung cancer. Credit: kvi123/Shutterstock. Summit Therapeutics has concluded subject enrolment in ...

The BHF claims women are less likely than men to seek medical attention when experiencing a cardiac episode.

The company has received clearance from the US FDA to start an open-label Phase I trial for RespiRx nicotine inhaler in ...

SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess casdatifan plus volrustomig for renal ...

The trial aims to enrol 87 subjects with low-grade intermediate-risk non-muscle invasive bladder cancer. Credit: Antonio Marca/Shutterstock. UroGen Pharma has announced the dosing of the first subject ...

On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy ...

Moderna has dosed the first subject in the US in its Phase III Nova 301 clinical trial of its investigational norovirus vaccine, mRNA-1403.

ProPharma is a global research consulting company and a Dual-Category Award Winner in the 2024 Clinical Trials Arena Excellence Awards. ProPharma, a global research consulting company headquartered in ...

Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.